IUPS AWARD Lectures 2022: (6) The Ernst-Knobil-Lecture

Ernst Knobil was 1st Vice President of the IUPS from 1997 to 2001. His work provided the basis for current understanding of the female reproductive system. His work enabled the development of the world’s first hormonal contraceptives.

The programme of our virtual congress 2022 (organized together with the Chinese Association of Physiological Sciences) has many highlights. Among them are the named IUPS lectures. The Ernst-Knobil-Lecture is awarded to an outstanding physiologist nominated by the IUPS commission “Endocrinology”. This year, the Ernst-Knobil-lecture will be given by Prof Matthias Tschöp. He is Chief Executive Officer and Scientific Director of Helmholtz Center in Munich, Germany, strategically leading 2600 scientists and staff in a research program focused on translational discoveries.

He received his M.D. from Ludwig Maximilian University of Munich, Germany, in1998. Further stations of his career were the Eli Lilly Research Laboratories in Indianapolis, USA, the German Institute of Human Nutrition (DIfE) in Potsdam, Germany, the University of Cincinnati (Diabetes and Obesity Center of Excellence) as well as the Technical University of Munich, Germany.

Matthias Tschöp is a physician, physiologist and clinical scientist highly cited for dissecting the molecular underpinnings of diabetes and obesity to discover and develop new preventive and therapeutic approaches. He is a pioneer who has driven innovative approaches for the long-term benefit of patients. Tschöp identified ghrelin as the hormone that signals hunger to the brain and thereby established one of the central pathways of modern metabolism research. He then dissected gut–brain communication to identify additional actionable targets against obesity and diabetes. Tschöp’s unique approach challenged traditional metabolism research, with a paradigm–shifting breakthrough being his demonstration that novel unimolecular polyagonists containing glucagon receptor activators which drive energy expenditure, while simultaneous GLP-1 and GIP incretin actions suppress appetite, improve insulin secretion and reduce hepatic glucose production. His work has been cited more than 63.000 times.

His lecture is entitled:  Hybrid Hormones against Obesity and Type 2 Diabetes: Discovery, Mechanism & Clinical Validation

We are looking forward to his lecture on May 8th, 2022!

Interested? You can still register for the congress